Characteristics of Patients with Diabetes Initiating Sodium Glucose Co-transporter-2 Inhibitors (SGLT2i): Real-World Results from Three Administrative Databases in Japan.
Yuichiro ItoJames Van SchyndleTakuya NishimuraToshifumi SugitaniTomomi KimuraPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2019)
Astellas Pharma Inc., Tokyo, Japan.
Keyphrases